Altered phenotype of dextran sulfate sodium colitis in interferon regulatory factor-1 knock-out mice

Journal of Gastroenterology and Hepatology (Australia)

Volumn 20, Issue 3, 2005, Pages 371-380

  Mannick, Elizabeth E ^a,b,c   Cote, Rae L ^a,b   Schurr, Jill R ^b   Krowicka, Halina S ^b   Sloop, Gregory D ^b   Zapata Velandia, Adriana ^a,b   Correa, Hernan ^b   Ruiz, Bernardo ^b   Horswell, Ronald ^a   Lentz, Jennifer J ^a,b   Byrne, Patrick ^b   Gastanaduy, M Mariella ^a,b   Hornick, Conrad A ^b   Liu, Zhiyun ^b  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Department of Pathology ^*  (United States)

^c TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Colitis; Dysplasia; Interferon regulatory factor 1; Microarray; Mouse

Indexed keywords

COMPLEMENTARY DNA; DEXTRAN SULFATE; INTERFERON REGULATORY FACTOR 1; RNA; TRANSCRIPTION FACTOR;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; CONTROLLED STUDY; DNA MICROARRAY; DYSPLASIA; HISTOLOGY; INFLAMMATION; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

EID: 20144389490     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2005.03573.x     Document Type: Article

References (65)

1. Grisham MB, Jourd'heuil D, Wink DA. Review article: chronic inflammation and reactive oxygen and nitrogen metabolism-implications in DNA damage and mutagenesis. Aliment. Pharmacol. Ther. 2000; 14 (Suppl. 1): 3-9.
2. O'Byrne KJ, Dalgleish AG. Chronic immune activation and inflammation as the cause of malignancy. Br. J. Cancer 2001; 85: 473-83.
3. Thun MJ, Henley SJ, Patrono C. Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. J. Natl. Cancer Inst. 2002; 94: 252-66.
4. Bernstein T, Szabo C, Salzman AL. Maturation-dependent sequential expression of interferon regulatory factor-1 and inducible nitric oxide synthase in cultured human enterocytes. Shock 2000; 14: 514-21.
5. Clavell M, Correa-Gracian H, Liu Z et al. Detection of interferon regulatory factor-1 in lamina propria mononuclear cells in Crohn's Disease. J. Pediatr. Gastroenterol. Nutr. 2000; 30: 43-7.
6. Henderson YC, Chou M, Deisseroth AB. Interferon regulatory factor 1 induces the expression of interferon-stimulated genes. Br. J. Heamatol 1997; 96: 566-75.
7. Lohoff M, Duncan GS, Ferrick D et al. Deficiency in the transcription factor interferon regulatory factor (IRF)-2 leads to severely compromised development of natural killer and T helper type 1 cells. J. Exp. Med. 2000; 192: 325-36.
8. McElligott DL, Phillips JA, Stillman CA et al. CD4+ T cells from IRP-1-deficient mice exhibit altered patterns of cytokine expression and cell subset homeostasis. J. Immunol. 1997; 159: 4180-6.
9. Taki S, Sato T, Ogasawara K et al. Multistage regulation of Th1-type immune responses by the transcription factor IRF-1. Immunity 1997; 6: 673-9.
10. Tada Y, Ho A, Matsuyama T et al. Reduced incidence and severity of antigen-induced autoimmune disease in mice lacking interferon regulatory factor-1. J. Exp. Med. 1997; 185: 231-8.
11. Nakazawa T, Satoh J, Takahashi K et al. Complete suppression of insulins and diabetes in NOD mice lacking interferon regulatory factor-1. J. Autoimmun. 2001; 17: 119-25.
12. Tanaka N, Ishihara M, Lamphier MS et al. Cooperation of the tumour suppressors IRF-1 and p53 in response to DNA damage. Nature 1996; 382: 816-18.
13. Tamura T, Ishihara M, Lamphier MS et al. DNA damage-induced apoptosis and Ice gene induction in mitogenically activated T lymphocytes require IRF-1. Leukemia 1997; 11 (Suppl. 3): 439-40.
14. Nozawa H, Oda E, Nakao K et al. Loss of transcription factor IRF-1 affects tumor susceptibility in mice carrying the Ha-ras transgene or nullizygosity for p53. Genes Dev. 1999; 13: 1240-5.
15. Tan RS, Taniguchi T, Harada H. Identification of the lysyl oxidase gene as target of the antioncogenic transcription factor, IRF-1, and its possible role in tumor suppression. Cancer Res. 1996; 56: 2417-21.
16. Chow WA, Fang JJ, Yee JK. The IFN regulatory factor family participates in regulation of Fas ligand gene expression in T cells. J. Immunol. 2000; 164: 3512-18.
17. Taniguchi T, Ogasawara K, Takaoka A et al. IRF family of transcription factors as regulators of host defense. Ann. Rev. Immunol. 2001; 19: 623-55.
18. Willman CL, Sever CE, Pallavicini MG et al. Deletion of IRF-, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia. Science 1993; 259: 968-71.
19. Nozawa H, Oda E, Ueda S et al. Functionally inactivating point mutation in the tumor-suppressor IRF-1 gene identified in human gastric cancer. Int. J. Cancer 1998; 77: 522-7.
20. Duncan GS, Mittrucker HW, Kagi D, Matsuyama T, Mak TW. The transcription factor interferon regulatory factor-1 is essential for natural killer cell function in vivo. J. Exp. Med. 1996; 184: 2043-8.
21. Yim JH, Wu SJ, Casey MJ, Norton JA, Doherry GM. IFN regulatory factor-1 gene transfer into an aggressive, non-immunogenic sarcoma suppresses the malignant phenotype and enhances immunogeniciry in syngeneic mice. J. Immunol. 1997; 158: 1284-92.
22. Ishioka T, Kuwabara N, Oohashi Y et al. Induction of colorectal tumors in rats by sulfated polysaccharides. Crit. Rev. Toxicol. 1987; 17: 215-44 (Review).
23. Harris RJ. A Primer of Multivariate Statistics. New York: Academic Press, 1975.
24. Dohi T, Fujihashi K, Rennert PD et al. Hapten-induced colitis is associated with colonic patch hypertrophy and helper cell 2-type responses. J. Exp. Med. 1999; 189: 1169-80.
25. Shamsuddin AM. Morphogenesis of colonic carcinoma. Ultrastructural studies of azosymethane-induced early lesions in colon epithelium of Fischer 344 rats. Arch. Pathol. Lab. Med. 1982; 106: 140-4.
26. Mansfield K, Teixeira CC, Adams CS et al. Phosphate ions mediate chondrocyte apoptosis through a plasma membrane transporter mechanism. Bone 2001; 28: 1-8.
27. Sanceau J, Hiscott J, Delattre O et al. IFN-beta induces serine phosphorylation of Stat-1 in Ewing's sarcoma cells and mediates apoptosis via induction of IRF-1 and activation of caspase-7. Oncogene 2000; 19: 3372-83.
28. Preckel T, Fung-Leung WP, Cai Z et al. Impaired immunoproteasome assembly and immune responses in PA28 -/- mice. Science 1999; 286: 2162-5.
29. Miyagi T, Tatsumi T, Kanto T et al. Impaired expression of proteasome subunits and human leukocyte antigens class I in human colon cancer cells. J. Gastroenterol. Hepatol. 2003; 18: 32-40.
30. Cabrera CM, Jimenez P, Cabrera T et al. Total loss of MHC class I in colorectal tumors can be explained by two molecular pathways: beta2-microglobulin inactivation in MSI-positive tumors and LMP7/TAP2 downregulation in MSI-negative tumors. Tissue Antigens 2003; 61: 211-19.
31. Yabe T, Kawamura S, Sato M et al. A subject with a novel type I bare lymphocyte syndrome has tapasin deficiency due to deletion of 4 exons by Alu-mediated recombination. Blood 2002; 100: 1496-8.
32. Bonifaz L, Bonnyay D, Mahnke K et al. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibiliry complex class I products and peripheral CD8+ T cell tolerance. J. Exp. Med. 2002; 196: 1627-38.
33. Shan X, Bourdeau A, Rhoton A et al. Characterization and mapping to human chromosome 8q24.3 of Ly-6-related gene 9804 encoding an apparent homologue of mouse TSA-1. J. Immunol. 1998; 160: 197-208.
34. Yu J, Abagyan R, Dong S et al. Mapping the active site of CD59. J. Exp. Med. 1997; 185: 745-53.
35. Classon BJ, Boyd RL. Thymic shared antigen-1 (TSA-1). A lymphostromal cell membrane Ly-6 superfamily molecule with a putative role in cellular adhesion. Dev. Immunol. 1998; 6: 149-56.
36. Chen BS, Wang MR, Xu X et al. Transglutaminase-3, an esophageal cancer-related gene. Int. J. Cancer 2000; 88: 862-5.
37. Lin CK, Lai KH, Lo GH et al. Cathepsin E and subtypes of intestinal metaplasia in carcinogenesis of the human stomach. Zhonghua Yi Xue Za Zhi (Taipei) 2001; 64: 331-6.
38. Falvella FS, Pascale RM, Gariboldi M et al. Stearoyl-CoA desaturase 1 (Scd1) gene overexpression is associated with genetic predisposition to hepatocarcinogenesis in mice and rats. Carcinogenesis 2002; 23: 1933-6.
39. Martinez-Chantar ML, Garcia-Trevijano ER, Latasa MU et al. Methionine adenosyltransferase II beta subunit gene expression provides a proliferative advantage in human hepatoma. Gastroenterology 2003; 124: 940-8.
40. Imaoka S, Yoneda Y, Sugimoto T et al. Androgen regulation of CYP4B1 mRNA by competitive reverse transcription-polymerase chain reaction. Cancer Lett. 2001; 166: 119-23.
41. Xie W, Yeuh MF, Radominska-Pandya A et al. Control of steroid, heme, and carcinogen metabolism by nuclear pregnane X receptor and constitutive androstane receptor. Proc. Natl. Acad. Sci. USA 2003; 100: 4150-5.
42. Fonnum F, Sterri SH, Aas P et al. Carboxylesterases, importance for detoxification of organophosphorus anti-cholinesterases and trichothecenes. Fundam. Appl. Toxicol. 1985; 5: S29-38.
43. Seward DJ, Koh AS, Boyer JL et al. Functional complementation between a novel mammalian polygenic transport complex and an evolutionarily ancient organic solute transporter, OSTalpha-OSTbeta. J. Biol. Chem. 2003; 278: 27473-82.
44. Greco C, Alvino S, Buglioni S et al. Activation of c-MYC and c-MYB proto-oncogenes is associated with decreased apoptosis in tumor colon progression. Anticancer Res. 2001; 21: 3185-92.
45. Borre A, Cultraro CM, Segal S. c-Myc inactivation by mutant Max alters growth and morphology of NCI-H-630 colon cancer cells. J. Cell. Physiol. 1996; 169: 200-8.
46. Collazo-Garcia N, Scherer P, Aplan PD. Cloning and characterization of a murine SIL gene. Genomics 1995; 30: 506-13.
47. Carmeliet P, Dor Y, Herbert JM et al Role of HIF-1 alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 1998; 394: 485-90.
48. Shi GP, Sukhova GK, Kuzuya M et al Deficiency of the cysteine protease cathepsin S impairs microvessel growth. Circ. Res. 2003; 92: 493-500.
49. Xu Y, Ma M, Ippolito GC et al. Complement activation in factor D-deficient mice. Proc. Natl. Acad. Sci. USA 2001; 98: 14577-82.
50. Mueller CG, Rissoan MC, Salinas B et al. Polymerase chain reaction selects a novel disintegrin proteinase from CD40-activated germinal center dendritic cells. J. Exp. Med. 1997; 186: 655-63.
51. Dwulet FE, Wallace DK, Benson MD. Amino acid structures of multiple forms of amyloid-related serum protein SAA from a single individual. Biochemistry 1988; 27: 677-1682.
52. Mortensen RF, Le PT, Taylor BA. Mouse serum amyloid P-component (SAP) levels controlled by a locus on chromosome 1. Immunogenetics 1985; 22: 367-75.
53. Takagi H, Kanai T, Okazawa A et al. Contrasting action of IL-12 and IL-18 in the development of dextran sodium sulphate colitis in mice. Scand. J. Gastroenterol. 2003; 38: 837-44.
54. Naito Y, Takagi T, Handa O et al. Enhanced intestinal inflammation induced by dextran sulfate sodium in tumor necrosis factor-alpha deficient mice. J. Gastroenterol. Hepatol. 2003; 18: 560-9.
55. Palmerini F, Devilard E, Jarry A et al. Caspase 7 down-regulation as an immunohistochemical marker of colonic carcinoma. Hum. Pathol 2001; 32: 461-7.
56. Collins JF, Bai L, Ghishan FK. The SLC20 family of proteins: dual functions as sodium-phosphate cotransporters and viral receptors. Pflugers Arch. 2004; 447: 647-52.
57. Hobart M, Ramassar V, Goes N et al. IFN regulatory factor-1 plays a central role in the regulation of the expression of class I and II MHC genes in vivo. J. Immunol. 1997; 158: 4260-9.
58. Garrido F, Algarra I. MHC antigens and tumor escape from immune surveillance. Adv. Cancer Res. 2001; 83: 117-58.
59. Hwang LY, Lieu PT, Peterson PA et al. Functional regulation of immunoproteasomes and transporter associated with antigen processing. Immunol. Res. 2001; 24: 245-72.
60. Fehling HJ, Swat W, Laplace C et al. MHC Class I expression in mice lacking the proteasome subunit LMP-7. Science 1994; 265: 1234-7.
61. Aliberti J, Schulz O, Pennington DJ et al. Essential role for ICSBP in the in vivo development of murine CD8alpha + dendritic cells. Blood 2003; 101: 305-10.
62. Gumley TP, Mckenzie IFC, Sandrin MS. Tissue expression, structure and function of the murine Ly-6 family of molecules. Immunol. Cell. Biol. 1995; 73: 277-96.
63. He G, Zhao Z, Fu W et al. Study of the loss of heterozygosity and expression of transglutaminase 3 gene in laryngeal carcinoma. Zhonghua Yi Sue Yi Chuan Xue Za Zhi 2002; 19: 120-3 (in Chinese).
64. Imaoka S, Yoneda Y, Matsuda T et al. Mutagenic activation of urinary bladder carcinogens by CYP4B and the presence of CYP4B1 in bladder mucosa. Biochem. Pharmacol. 1997; 54: 677-83.
65. Elson CO, Sartor RB, Tennyson GS et al. Experimental models of inflammatory bowel disease. Gastroenterology 1995; 109: 1344-67.